{
    "nct_id": "NCT04883762",
    "official_title": "Fecal Microbiota Transplantation (FMT) for Immune Checkpoint Inhibitor (ICI)-Related Diarrhea: A Pilot Study",
    "inclusion_criteria": "* ≥ 18 years old\n* Patient has been treated with immune checkpoint inhibitors (ICI), including anti-CTLA-4, anti-PD-1 and anti-PDL-1 therapy for any malignant indication\n* Patient has developed diarrhea ≥ Grade 2 attributed to ICI\n* Patient has diarrhea ≥ Grade 2 attributed to ICI, that persists despite treatment with corticosteroids for at least 72 hours and/or at least one dose of a biologic medication, such as infliximab or vedolizumab, with symptoms that persist or recur at least 72 hours post-infusion ° If no to the above, patient has a contraindictation to immunosuppressive treatment\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Active GI infection, including untreated viral, bacterial or fungal or alternative identified cause(s) of diarrhea.\n* Antibiotic exposure within 48 hours prior to FMT\n* Expected prolonged compromised immunity indicated by at least one of the below:\n\n  * Known HIV infection with CD4 count <240\n  * ANC <1000/mm3 (use of growth factors to raise ANC is acceptable)\n* Seronegative for EBV or CMV (i.e. EBV IgG negative or CMV IgG negative)\n* Contraindications to anesthesia for procedure indicated by at least one of the below:\n\n  * Serious cardiopulmonary comorbidities\n  * Inability to tolerate anesthesia\n* Pregnancy\n\n  * Patient is pregnant\n  * Women of childbearing potential should not have plans to became pregnant or breastfeed an infant and must agree to use a highly effective method of birth control until 2 months after treatment with FMT (e.g. barrier method, oral or parenteral contraceptives, a vasectomized partner, or abstinence from sexual intercourse)\n* Severe food allergies",
    "miscellaneous_criteria": ""
}